RSV, influenza, COVID-19 and monkeypox have dominated vaccine discussions this year, but vaccines are also being developed for a host of other infectious diseases.
https://www.pharmalive.com/wp-content/uploads/2022/05/BioSpacevaccine5-24-2022.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-11-16 08:51:042022-11-16 09:02:35Beyond COVID-19 and RSV, emerging vaccines target less common conditions